Nurse Practitioner, Adult Health · Greenvale, NY
NPI
1811432982
Since 2016
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2200 Northern Blvd, The Cancer Institute
Greenvale, NY, 11548
Phone (516) 325-7513
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,377
46 services
Medicare patients, 2024
39
Average age 77
Drug cost, 2024
$5.6M
590 prescriptions
Company payments, 2025
$228
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ann Way was code 99213 (office e&m - established), 30 times for 25 patients. In total Ann Way billed 46 services in 8 codes, and Medicare paid $3,377.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 30 | 25 | $62.66 | $1,880 |
By year: 2023 $3,164 for 24 services; 2024 $3,377 for 46 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ann Way prescribed most often to Medicare patients was Imbruvica (Ibrutinib), with 65 prescriptions and refills. In total Ann Way wrote 590 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imbruvica Ibrutinib | 65 | 65 | Under 11 | $1.0M |
| Acyclovir Generic | 49 | 60 | Under 11 | $545 |
| Brukinsa Zanubrutinib | 42 | 42 | Under 11 | $616K |
| Prednisone Generic | 37 | 39 | Under 11 | $261 |
| Calquence Acalabrutinib Maleate | 29 | 31 | Under 11 | $451K |
| Deferasirox Generic | 23 | 23 | Under 11 | $15K |
| Imatinib Mesylate Generic | 20 | 20 | Under 11 | $48K |
| Ferriprox (2 Times A Day) Deferiprone | 19 | 19 | Under 11 | $492K |
| Lenalidomide Generic | 15 | 15 | Under 11 | $241K |
| Enoxaparin Sodium Generic | 15 | 23 | Under 11 | $4,838 |
| Hydroxyurea Generic | 14 | 33 | Under 11 | $626 |
| Jaypirca Pirtobrutinib | 14 | 14 | Under 11 | $310K |
| Pegasys Peginterferon Alfa-2a | 13 | 13 | Under 11 | $63K |
| Zolpidem Tartrate Generic | 13 | 13 | Under 11 | $36.34 |
| Pomalyst Pomalidomide | 12 | 12 | Under 11 | $319K |
Brand drugs: 303 claims; generic drugs: 287 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ann Way $228 ($228 in general payments such as food, travel and fees) from 2 companies. The largest payer was PharmaEssentia USA Corporation with $121.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.